Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
EPS for Capricor Therapeutics (CAPR)
EPS in 2023 (TTM): -$1.17
According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$1.18 a decrease over its 2021 EPS that were of -$0.87.
EPS history for Capricor Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.17 | -0.85% |
| 2022 | -$1.18 | 35.63% |
| 2021 | -$0.87 | -7.45% |
| 2020 | -$0.94 | -55.45% |
| 2019 | -$2.11 | -59.81% |
| 2018 | -$5.25 | -1850% |
| 2017 | $0.30 | -102.94% |
| 2016 | -$10.20 | 25.93% |
| 2015 | -$8.10 | 55.77% |
| 2014 | -$5.20 | -39.53% |
| 2013 | -$8.60 | -64.78% |
| 2012 | -$24.41 | -62.44% |
| 2011 | -$65.00 | -31.58% |
| 2010 | -$95.00 | -38.71% |
| 2009 | -$155.00 | -43.64% |
| 2008 | -$275.00 | -5.17% |
| 2007 | -$290.00 | 427.27% |
| 2006 | -$55.00 | 340.33% |
| 2005 | -$12.49 | |
| 2004 | N/A | |
| 2003 | N/A | |
| 2002 | N/A | |
| 2001 | N/A |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -1,303.87% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.96 | -267.52% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$5.69 | 386.32% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | 105.13% | 🇺🇸 USA |
 Palatin Technologies PTN | -$2.96 | 152.99% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$5.64 | 382.05% | 🇺🇸 USA |